OpenAI targets life sciences sector

The model is designed to assist researchers in identifying complex biological patterns and accelerating the development of new therapeutics.

OpenAI executives stated that the tool is intended for 'high-value professional work' and will be available in a closed-access format.

The move comes as tech giants like Google and Microsoft also ramp up their investments in AI-driven scientific research.

Industry experts believe that biology-focused LLMs could significantly reduce the time and cost of bringing new drugs to market.